InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Bogle Grant C., Director. Director active across 2 companies, notably Epizyme, Inc.. Aggregated, 10 filings have been logged. Activity tracked since 11 June 2021. The latest transaction was disclosed on 5 December 2024 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations10 total
3,444 sharesClass A Common StockSEC:0001646675-26-000002:0
3,200 shares0Class A Common StockSEC:0000950170-24-134328:0
84,170 sharesCommon Stock, par value $0.0001SEC:0000899243-22-028851:0
800,000 shares@ US$1.39100.0% of flowCommon Stock, par value $0.0001SEC:0000899243-22-028421:0
87,500 shares0Common Stock, par value $0.0001SEC:0000899243-22-004828
87,500 shares0Common Stock, par value $0.0001SEC:0000899243-22-004828:0
87,500 shares0Common Stock, par value $0.0001SEC:0000899243-21-033401:0
87,500 shares0Common Stock, par value $0.0001SEC:0000899243-21-033401
8,060 shares0Common Stock, par value $0.0001SEC:0000899243-21-023877
8,060 shares0Common Stock, par value $0.0001SEC:0000899243-21-023877:0
10 of 10 declarations
About Bogle Grant C.
Grant C. Bogle is a Board Member at Epizyme, Inc. He plays a key role in the company's governance, bringing his expertise to guide strategic decisions. His experience in the biopharmaceutical sector allows him to contribute to innovation and operational efficiency within the company.
